Alivus Life Sciences to host Q1 FY2026-27 earnings call on July 31
Alivus Life Sciences Ltd announced it will hold an earnings call for Q1 FY2026-27 on July 31, 2026, from 8:30 am to 9:30 am IST. The company provided a comprehensive list of domestic and international dial-in numbers for access. Pre-registration is available online for interested participants.
*this image is generated using AI for illustrative purposes only.
Alivus Life Sciences Ltd will conduct an earnings call to discuss its financial performance for the first quarter of FY2026-27. The conference is scheduled for Friday, July 31, 2026, from 8:30 am to 9:30 am IST. This session allows investors and analysts to review the company's quarterly results and operational outlook directly with management.
The company has provided universal dial-in numbers for participants within India. International attendees can access the call via designated toll-free numbers for regions including Australia, Canada, China, Hong Kong, Italy, Japan, Singapore, South Korea, the UK, and the USA. Toll numbers are also available for Hong Kong, Japan, Singapore, South Africa, the UK, and the USA.
Dial-in Details
Universal Dial-in Numbers
| Number |
|---|
| +91 22 6280 1564 |
| +91 22 7115 8394 |
International Toll-Free Access
| Country | Number |
|---|---|
| Australia | 1800053698 |
| Canada | 01180014243444 |
| China | 4008428405 |
| Hong Kong | 800964448 |
| Italy | 0080014243444 |
| Japan | 00531161110 |
| Singapore | 8001012045 |
| South Korea | 00180014243444 |
| UK | 08081011573 |
| USA | 18667462133 |
International Toll Access
| Country | Number |
|---|---|
| Hong Kong | +852 30186877 |
| Japan | +81 345899421 |
| Singapore | +65 31575746 |
| South Africa | +27 110623033 |
| UK | +44 2034785524 |
| USA | +1 3233868721 |
Participants can pre-register online for the event. For further clarification regarding the earnings call, stakeholders may contact Diwakar Pingle or Runjhun Jain via email.
Historical Stock Returns for Alivus Life Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.13% | -5.61% | +2.02% | +28.01% | +5.14% | +47.33% |
What key financial metrics will investors focus on during the Q1 FY2026-27 earnings call?
How might the company's operational outlook impact its stock performance post-earnings?
What strategic initiatives or market trends could Alivus Life Sciences highlight during the call?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
